Search results
Results from the WOW.Com Content Network
BMC Genomics is an open-access scientific journal covering all areas of genomics and proteomics. The journal was established in 2000 and is published by BioMed Central . Its 2022 impact factor is 4.4.
BioMed Central (BMC) is a United Kingdom-based, for-profit scientific open access publisher that produces over 250 scientific journals. All its journals are published online only. All its journals are published online only.
"When I Fall in Love" is a popular song, written by Victor Young (music) and Edward Heyman (lyrics). It was introduced in Howard Hughes ' last film One Minute to Zero as the instrumental titled "Theme from One Minute to Zero".
BMC Biology is an online open access scientific journal that publishes original, peer-reviewed research in all fields of biology, together with opinion and comment articles. [2] The publication was established in 2003. [3] The journal is part of a series of BMC journals published by the UK-based publisher BioMed Central, owned by Springer Nature.
Genomics is a peer-reviewed scientific journal in genomics, publishing articles on topics such as comparative genomics, functional genomics, association studies, regulatory DNA elements, and genetics on a genome-wide scale. [1] [2] The journal was established in September 1987. [3]
BMC Medicine is a peer-reviewed open access medical journal published since 2003 by BioMed Central. The journal is abstracted and indexed in Chemical Abstracts Service, BIOSIS Previews, Embase, MEDLINE, Science Citation Index Expanded, and Scopus. According to the Journal Citation Reports, the journal has a 2022 impact factor of 9.3. [1]
BMC Biomedical Engineering is a peer-reviewed open-access scientific journal that covers the interdisciplinary field of biomedical engineering, encompassing aspects such as biomaterials, bioinformatics, biomechanics, and medical imaging. The associate editor is Sara Zandomeneghi, with Biyas Bandyopadhyay, serving as the assistant editor. [1]
Although other factors contribute to the slow progression of pharmacogenomics (such as developing guidelines for clinical use), the above factors appear to be the most prevalent. Increasingly substantial evidence and industry body guidelines for clinical use of pharmacogenetics have made it a population wide approach to precision medicine.